FNDX |
Letter confirming receipt of proceeds |
Autre |
28/03/2024 |
Open Filing (82.5 Ko) |
FNDX |
Form 6 - Certificate of Compliance |
Certificat de conformité |
28/03/2024 |
Open Filing (152.42 Ko) |
FNDX |
Form 10 - Notice of Proposed Significant Transaction |
Transaction proposée |
28/03/2024 |
Open Filing (132 Ko) |
POLE |
Form 7 February 2024 |
Rapport d'activité mensuel |
28/03/2024 |
Open Filing (142.66 Ko) |
POLE |
Form 7 January |
Rapport d'activité mensuel |
28/03/2024 |
Open Filing (142.64 Ko) |
RAMM |
RAMM Pharma Corp. Announces Corporate Update |
Communiqué de presse |
28/03/2024 |
Open Filing (223.73 Ko) |
MUSK |
Notice of Proposed New RSU Grant |
Proposition d'options d'achat |
28/03/2024 |
Open Filing (149.63 Ko) |
NLR |
Certificate - CEO |
Certificat de conformité |
28/03/2024 |
Open Filing (193.48 Ko) |
NLR |
Certificate - CFO |
Certificat de conformité |
28/03/2024 |
Open Filing (192.6 Ko) |
NLR |
Quarterly Financials for the period ending January 31, 2024 |
États financiers intermédiaires |
28/03/2024 |
Open Filing (630.7 Ko) |